- Home
- RCUS vs AAT Comparison
RCUS vs AAT Comparison
Compare RCUS & AAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- AAT
- Stock Information
- Founded
- RCUS 2015
- AAT 1967
- Country
- RCUS United States
- AAT United States
- Employees
- RCUS N/A
- AAT N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- AAT Real Estate Investment Trusts
- Sector
- RCUS Health Care
- AAT Real Estate
- Exchange
- RCUS Nasdaq
- AAT Nasdaq
- Market Cap
- RCUS 1.2B
- AAT 1.3B
- IPO Year
- RCUS 2018
- AAT 2011
- Fundamental
- Price
- RCUS $11.07
- AAT $21.84
- Analyst Decision
- RCUS Buy
- AAT Hold
- Analyst Count
- RCUS 11
- AAT 2
- Target Price
- RCUS $31.11
- AAT $26.00
- AVG Volume (30 Days)
- RCUS 1.1M
- AAT 314.9K
- Earning Date
- RCUS 02-25-2025
- AAT 02-04-2025
- Dividend Yield
- RCUS N/A
- AAT 6.19%
- EPS Growth
- RCUS N/A
- AAT 12.42
- EPS
- RCUS N/A
- AAT 0.94
- Revenue
- RCUS $263,000,000.00
- AAT $453,339,000.00
- Revenue This Year
- RCUS $127.65
- AAT N/A
- Revenue Next Year
- RCUS N/A
- AAT $1.87
- P/E Ratio
- RCUS N/A
- AAT $23.39
- Revenue Growth
- RCUS 119.17
- AAT 3.79
- 52 Week Low
- RCUS $10.63
- AAT $20.03
- 52 Week High
- RCUS $20.31
- AAT $29.15
- Technical
- Relative Strength Index (RSI)
- RCUS 34.34
- AAT 32.68
- Support Level
- RCUS $10.63
- AAT $21.53
- Resistance Level
- RCUS $13.49
- AAT $22.60
- Average True Range (ATR)
- RCUS 0.77
- AAT 0.50
- MACD
- RCUS -0.13
- AAT -0.03
- Stochastic Oscillator
- RCUS 13.88
- AAT 11.07
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About AAT American Assets Trust Inc.
American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.